WASOPHARMA
ActiveSummary
WASOPHARMA is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €4k and a net result of €3k. Its solvency ranks better than 50% of 18280 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Every signal that weighs is under Signals.
Axes
Profitability97
Solvency59
Growth-
Track record50
Credit advice for your own amount and term
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
1 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2025, micro schema
Equity
€4k
Total assets
€11k
Net result
€3k
Working capital
€4k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €11k
Equity
€4k
Debt
€7k
Debt finances 65.8% of the balance-sheet total.
Key figures and ratios
Current ratio
1.52
Debt to equity
1.93
ROE
69.8%
ROA
23.8%
Debt ≤ 1 year
€7k
Income taxes
€779
Filed annual accounts As filed with the NBB · 2025 · 29 lines
Balance sheet
Code2025
Assets
Total assets20/58€11k
Current assets29/58€11k
Amounts receivable within one year40/41€6k
Trade receivables40€6k
Cash at bank and in hand54/58€6k
Equity and liabilities
Total equity and liabilities10/49€11k
Equity10/15€4k
Contributions10/11€2k
Profit (loss) carried forward14€2k
Amounts payable17/49€7k
Amounts payable within one year42/48€7k
Trade debts44€986
Suppliers440/4€986
Taxes, remuneration and social security45€6k
Taxes450/3€6k
Other amounts payable47/48€583
Income statement
Code2025
Gross operating margin9900€3k
Operating profit (loss)9901€3k
Financial income75/76B€0
Recurring financial income75€0
Financial charges65/66B€8
Recurring financial charges65€8
Profit (loss) for the period before taxes9903€3k
Income taxes67/77€779
Profit (loss) for the period9904€3k
Profit (loss) for the period to be appropriated9905€3k
Appropriation of the result
Profit (loss) to be appropriated9906€3k
Profit to be distributed694/7€833
Return on contributions (dividend)694€833
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nivelles · 1 establishment unit since 2025
Ground area
191 m²
Building footprint
54 m²
Parcel 25782C0400/00R006, Wallonia. Linked by address, not a title deed.
1 establishment unit
WASOPHARMA
since 20252.380.237.666
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25782C0400/00R006 | Wallonia | 191 m² | 1 · 54 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE DES VIADUCS
BE 0476.396.791
Mons · Eq €3,820
Styrax
BE 0792.694.787
Merchtem · Eq €3,814
Manon De Marez
BE 0790.192.880
Herent · Eq €3,923
Aston Luxembourg
BE 0837.030.618
Marche-en-Famenne · Eq €3,960
Rick Voeten
BE 0766.425.407
Turnhout · Eq €4,000
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 368 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded13-10-2025
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
82990Other business support services
85599Other education
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:[email protected]
Phone:0497/60.02.96